Lysosomes as targets for cancer therapy.
暂无分享,去创建一个
[1] J. Kos,et al. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.
[2] Jiahuai Han,et al. Susceptibility of Lysosomes to Rupture Is a Determinant for Plasma Membrane Disruption in Tumor Necrosis Factor Alpha-Induced Cell Death , 2003, Molecular and Cellular Biology.
[3] G. Gores,et al. Lysosomes in cell death , 2004, Oncogene.
[4] C. Gondi,et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis , 2004, Oncogene.
[5] J. Nylandsted,et al. Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization , 2004, The Journal of experimental medicine.
[6] E. C. Toescu. Patching the membranes up ‐ new views on cellular healing , 2003, Journal of cellular and molecular medicine.
[7] J. Pober,et al. Inhibition of Phosphatidylinositol 3-Kinase Sensitizes Vascular Endothelial Cells to Cytokine-initiated Cathepsin-dependent Apoptosis* , 2003, Journal of Biological Chemistry.
[8] J. Eaton,et al. Lysosomal involvement in apoptosis. , 1998, Redox report : communications in free radical research.
[9] Kane Se,et al. The role of cathepsin L in malignant transformation. , 1990 .
[10] D. Hanahan,et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.
[11] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[12] Bonnie F. Sloane,et al. Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[13] J. Deussing,et al. Towards Specific Functions of Lysosomal Cysteine Peptidases: Phenotypes of Mice Deficient for Cathepsin B or Cathepsin L , 2001, Biological chemistry.
[14] M. Peter,et al. NF‐κB protects from the lysosomal pathway of cell death , 2003, The EMBO Journal.
[15] P Kronqvist,et al. Cysteine proteinase inhibitor cystatin A in breast cancer. , 1998, Cancer research.
[16] U. Felbor,et al. Sensitization to the Lysosomal Cell Death Pathway upon Immortalization and Transformation , 2004, Cancer Research.
[17] G. Tortora,et al. Resistance to taxanes is induced by c‐erbB‐2 overexpression in human MCF‐10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A , 2000, International journal of cancer.
[18] R. Myers,et al. Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins* , 2004, Journal of Biological Chemistry.
[19] M. Jäättelä,et al. Multiple cell death pathways as regulators of tumour initiation and progression , 2004, Oncogene.
[20] M. Gottesman,et al. The role of cathepsin L in malignant transformation. , 1990, Seminars in cancer biology.
[21] J. Castro,et al. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. de Duve. Lysosomes revisited. , 1983, European journal of biochemistry.
[23] Bonnie F. Sloane,et al. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. , 1994, Journal of cell science.
[24] A. Brech,et al. Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. , 2003, The Biochemical journal.